ZA200901075B - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
ZA200901075B
ZA200901075B ZA200901075A ZA200901075A ZA200901075B ZA 200901075 B ZA200901075 B ZA 200901075B ZA 200901075 A ZA200901075 A ZA 200901075A ZA 200901075 A ZA200901075 A ZA 200901075A ZA 200901075 B ZA200901075 B ZA 200901075B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical composition
fat
substance
oil
active ingredient
Prior art date
Application number
ZA200901075A
Other languages
English (en)
Inventor
Yukihiro Nomura
Muneo Nonomura
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of ZA200901075B publication Critical patent/ZA200901075B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245Oxadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200901075A 2006-08-10 2007-08-09 Pharmaceutical composition ZA200901075B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006218145 2006-08-10

Publications (1)

Publication Number Publication Date
ZA200901075B true ZA200901075B (en) 2010-05-26

Family

ID=39033098

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200901075A ZA200901075B (en) 2006-08-10 2007-08-09 Pharmaceutical composition

Country Status (25)

Country Link
US (1) US20100016382A1 (fr)
EP (1) EP2058010B1 (fr)
JP (2) JP5361188B2 (fr)
KR (1) KR101464007B1 (fr)
CN (3) CN103610673A (fr)
AT (1) ATE555777T1 (fr)
AU (1) AU2007282400B2 (fr)
BR (1) BRPI0716030A2 (fr)
CA (1) CA2660427A1 (fr)
CO (1) CO6150195A2 (fr)
CR (1) CR10632A (fr)
EA (1) EA016728B1 (fr)
ES (1) ES2382902T3 (fr)
GE (1) GEP20125420B (fr)
HK (1) HK1133817A1 (fr)
IL (1) IL196853A0 (fr)
MA (1) MA30759B1 (fr)
MX (1) MX2009001429A (fr)
MY (1) MY147310A (fr)
NO (1) NO20090759L (fr)
NZ (1) NZ574954A (fr)
TN (1) TN2009000042A1 (fr)
UA (1) UA96302C2 (fr)
WO (1) WO2008018569A1 (fr)
ZA (1) ZA200901075B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008006083A2 (fr) 2006-07-07 2008-01-10 Surmodics, Inc. Dispositif espaceur de plaie à billes
FR2928836B1 (fr) * 2008-03-21 2011-08-26 Servier Lab Forme galenique secable permettant une liberation modifiee du principe actif
UY32017A (es) 2008-07-31 2010-02-26 Takeda Pharmaceutical Composición farmacéutica sólida
KR101275092B1 (ko) * 2011-05-19 2013-06-17 한미정밀화학주식회사 아질사르탄의 개선된 제조방법
KR101316653B1 (ko) * 2011-05-19 2013-10-10 한미정밀화학주식회사 헤테로고리 화합물의 제조방법
KR20140030237A (ko) * 2011-05-23 2014-03-11 지앙수 헨그루이 메디슨 컴퍼니 리미티드 벤즈이미다졸 유도체를 함유하는 고체 약제학적 조성물
CN103113364B (zh) * 2012-08-27 2015-11-18 南京华威医药科技开发有限公司 阿齐沙坦多晶型的制备方法
CN103705510A (zh) * 2013-12-27 2014-04-09 华润赛科药业有限责任公司 一种阿齐沙坦固体组合物的制备方法
US10201457B2 (en) 2014-08-01 2019-02-12 Surmodics, Inc. Wound packing device with nanotextured surface
EP3288556A4 (fr) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Compositions à désintégration par voie orale
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
JP6895779B2 (ja) * 2017-03-17 2021-06-30 東和薬品株式会社 アジルサルタン含有固形医薬組成物
CN109223723B (zh) * 2017-07-11 2021-08-27 南京华威医药科技集团有限公司 吡非尼酮片剂及其制备方法和用途
WO2019130277A1 (fr) 2017-12-30 2019-07-04 Lupin Limited Formulations pharmaceutiques d'azilsartan médoxomil
WO2019246503A1 (fr) 2018-06-22 2019-12-26 Ideaz, Llc Comprimés de diphényle et leurs procédés de préparation
CN111617046A (zh) * 2020-07-09 2020-09-04 浙江诺得药业有限公司 阿齐沙坦分散片及其制备工艺
CN115531350B (zh) * 2022-11-03 2024-01-05 珠海润都制药股份有限公司 一种阿齐沙坦胶囊及其制备方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01308231A (ja) * 1988-06-03 1989-12-12 Takeda Chem Ind Ltd 安定化された医薬組成物および製造法
CA2017916C (fr) * 1989-06-07 1999-02-02 Minoru Aoki Preparations a base d'etoposide
IL95975A (en) 1989-10-24 1997-06-10 Takeda Chemical Industries Ltd N-benzyl- 2-alkylbenzimidazole derivatives, their production and pharmaceutical compositions containing them
US5196444A (en) 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
IL102183A (en) * 1991-06-27 1999-11-30 Takeda Chemical Industries Ltd The heterocyclic compounds are converted into biphenyl groups, their production and the pharmaceutical compositions containing them
JP2682353B2 (ja) * 1991-11-20 1997-11-26 武田薬品工業株式会社 経口用医薬組成物およびその製造法
TW284688B (fr) * 1991-11-20 1996-09-01 Takeda Pharm Industry Co Ltd
EP0616841B1 (fr) * 1992-10-09 1998-12-23 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Procede de production de granules fins
CN1044088C (zh) * 1992-11-13 1999-07-14 武田药品工业株式会社 口服药物组合物及制备方法
US5721263A (en) * 1993-06-07 1998-02-24 Takeda Chemical Industries, Ltd. Pharmaceutical composition for angiotensin II-mediated diseases
JP3057471B2 (ja) * 1993-06-07 2000-06-26 武田薬品工業株式会社 アンジオテンシンii介在性諸疾患の予防または治療剤
JPH1135451A (ja) * 1994-07-27 1999-02-09 Yamanouchi Pharmaceut Co Ltd 口腔内溶解型錠剤およびその製造方法
BR9908474A (pt) * 1998-03-04 2000-12-05 Takeda Chemical Industries Ltd Preparação de liberação prolongada, processo para a produção de uma preparação de liberação prolongada, e, composição farmacêutica
JPH11315034A (ja) * 1998-03-04 1999-11-16 Takeda Chem Ind Ltd アンギオテンシンii拮抗作用を有する化合物の徐放性製剤、その製造法および用途
CN1195500C (zh) * 1998-05-18 2005-04-06 武田药品工业株式会社 可口腔崩解的片剂
JP2000053563A (ja) * 1998-08-07 2000-02-22 Bayer Yakuhin Ltd 苦味がマスクされた速放性細粒剤
ZA200506397B (en) * 2003-01-29 2006-11-29 Takeda Pharmaceutical Process for producing coated preparation
JP4567340B2 (ja) * 2003-01-29 2010-10-20 武田薬品工業株式会社 被覆製剤の製造方法
CA2514539C (fr) * 2003-01-29 2012-03-06 Takeda Pharmaceutical Company Limited Procede pour realiser une preparation enrobee
ZA200409537B (en) * 2003-01-31 2006-10-25 Yamanouchi Pharma Co Ltd Stable solid medicinal composition for oral administration
US7442387B2 (en) * 2003-03-06 2008-10-28 Astellas Pharma Inc. Pharmaceutical composition for controlled release of active substances and manufacturing method thereof
JP2006218145A (ja) 2005-02-14 2006-08-24 My Kk キャリーバッグ
ES2366381T3 (es) * 2005-06-22 2011-10-19 Takeda Pharmaceutical Company Limited Comprimido que contiene un ingrediente activo difícilmente soluble.

Also Published As

Publication number Publication date
CO6150195A2 (es) 2010-04-20
GEP20125420B (en) 2012-03-26
WO2008018569A1 (fr) 2008-02-14
JPWO2008018569A1 (ja) 2010-01-07
EP2058010A1 (fr) 2009-05-13
ATE555777T1 (de) 2012-05-15
CN102813635A (zh) 2012-12-12
NZ574954A (en) 2011-11-25
JP2011168622A (ja) 2011-09-01
MA30759B1 (fr) 2009-10-01
AU2007282400B2 (en) 2012-08-30
EA200970188A1 (ru) 2009-08-28
CA2660427A1 (fr) 2008-02-14
ES2382902T3 (es) 2012-06-14
TN2009000042A1 (en) 2010-08-19
NO20090759L (no) 2009-03-11
EP2058010A4 (fr) 2009-09-30
US20100016382A1 (en) 2010-01-21
IL196853A0 (en) 2009-11-18
HK1133817A1 (en) 2010-04-09
MY147310A (en) 2012-11-30
CN103610673A (zh) 2014-03-05
KR101464007B1 (ko) 2014-11-20
JP5361188B2 (ja) 2013-12-04
CR10632A (es) 2009-04-14
UA96302C2 (en) 2011-10-25
KR20090050071A (ko) 2009-05-19
MX2009001429A (es) 2009-02-17
BRPI0716030A2 (pt) 2013-07-30
EP2058010B1 (fr) 2012-05-02
CN101528262A (zh) 2009-09-09
AU2007282400A1 (en) 2008-02-14
EA016728B1 (ru) 2012-07-30

Similar Documents

Publication Publication Date Title
ZA200901075B (en) Pharmaceutical composition
ATE413162T1 (de) Pharmazeutische zusammensetzungen zur sicheren verabreichung von bei der behandlung von drogenabhängigkeit verwendeten arzneimitteln
ZA200702536B (en) Low oil emulsion compositions for delivering taxolds and other insoluble drugs
TW200633716A (en) Compositions and methods for stabilizing active pharmaceutical ingredients
EA200701065A1 (ru) Инъецируемые составы, содержащие нанодисперсный оланзапин
SI1765293T1 (sl) Farmacevtski sestavki za aplikacijo zdravil in postopki za zdravljenje ali preventivo stanj z njihovo uporabo
EP1894567A4 (fr) Agents pharmaceutiques concomitants et leur utilisation
MX336861B (es) Formulacion de farmaco resistente al abuso.
WO2007111864A3 (fr) Composes antagonistes du recepteur du glucagon, compositions contenant de tels composes et procedes d'utilisation
WO2007136577A3 (fr) Composés antagonistes du récepteur du glucagon, compositions contenant ces composés, et procédés d'utilisation
BRPI0508540B8 (pt) composto, composição farmacêutica, e, uso de um composto
WO2005112633A3 (fr) Composes et compositions pour administration d’agents actifs
EA200801213A1 (ru) Игла для прокалывания капсул с порошком для ингаляции
WO2007095043A3 (fr) Formulations pharmaceutiques
EA200870060A1 (ru) Эмульсия бутилфталида для внутривенного введения и ее применение
TW200616616A (en) Paclitaxel aqueous injection solution and methods for preparing the same
DK1432402T3 (da) Sammensætning til tilförsel af lægemiddelkombinationer
PT1358177E (pt) Tratamento de desordens afectivas atraves da accao combinada de um agonista do receptor nicotinico e uma substancia manoaminergica
EA200501697A1 (ru) Дозируемая форма, содержащая пантопразол в качестве активного ингредиента
IS8428A (is) Innrennslislyf sem inniheldur (2R)-2-própýloktansýru sem virka efnisþáttinn
WO2005123113A3 (fr) Compositions d'interferons et leurs methodes d'utilisation
DK1976538T3 (da) Farmaceutisk formulering til behandling af slidgigt indeholdende clodronsyre og hyaluronsyre
ATE460934T1 (de) Pharmazeutische zubereitungen von ciprofloxacin
EP1765293A4 (fr) Compositions pharmaceutiques destinees a l'administration medicamenteuse et methodes de traitement ou de prevention d'etats au moyen de celles-ci
EP1603595A4 (fr) Composition pharmaceutique pour le traitement de la pharmacodependance